157 related articles for article (PubMed ID: 28321652)
1. Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice.
Tamura Y; Kawao N; Shimoide T; Okada K; Matsuo O; Kaji H
J Bone Miner Metab; 2018 Mar; 36(2):148-156. PubMed ID: 28321652
[TBL] [Abstract][Full Text] [Related]
2. Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice.
Tamura Y; Kawao N; Yano M; Okada K; Okumoto K; Chiba Y; Matsuo O; Kaji H
Diabetes; 2015 Jun; 64(6):2194-206. PubMed ID: 25552599
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 deficiency suppresses osteoblastic differentiation of mesenchymal stem cells in mice.
Takafuji Y; Tatsumi K; Ishida M; Kawao N; Okada K; Matsuo O; Kaji H
J Cell Physiol; 2019 Jun; 234(6):9687-9697. PubMed ID: 30387130
[TBL] [Abstract][Full Text] [Related]
4. PAI-1 is involved in delayed bone repair induced by glucocorticoids in mice.
Okada K; Okamoto T; Okumoto K; Takafuji Y; Ishida M; Kawao N; Matsuo O; Kaji H
Bone; 2020 May; 134():115310. PubMed ID: 32142912
[TBL] [Abstract][Full Text] [Related]
5. Role of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair Induced by Glucocorticoids in Mice.
Okada K; Kawao N; Nakai D; Wakabayashi R; Horiuchi Y; Okumoto K; Kurashimo S; Takafuji Y; Matsuo O; Kaji H
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008904
[TBL] [Abstract][Full Text] [Related]
6. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
7. Regulation of plasminogen activator inhibitor (PAI)-1 expression in a human trophoblast cell line by glucocorticoid (GC) and transforming growth factor (TGF)-beta.
Ma Y; Ryu JS; Dulay A; Segal M; Guller S
Placenta; 2002 Nov; 23(10):727-34. PubMed ID: 12398812
[TBL] [Abstract][Full Text] [Related]
8. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
9. Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats.
Yin HN; Chai JK; Yu YM; Shen CA; Wu YQ; Yao YM; Liu H; Liang LM; Tompkins RG; Sheng ZY
J Trauma; 2009 Apr; 66(4):1083-90. PubMed ID: 19359918
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice.
Tamura Y; Kawao N; Yano M; Okada K; Matsuo O; Kaji H
Endocrinology; 2014 May; 155(5):1708-17. PubMed ID: 24605827
[TBL] [Abstract][Full Text] [Related]
11. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 is involved in glucocorticoid-induced decreases in angiogenesis during bone repair in mice.
Okada K; Niwa Y; Fukuhara K; Ohira T; Mizukami Y; Kawao N; Matsuo O; Kaji H
J Bone Miner Metab; 2024 May; 42(3):282-289. PubMed ID: 38704516
[TBL] [Abstract][Full Text] [Related]
13. Role of plasminogen activator inhibitor-1 in muscle wasting induced by a diabetic state in female mice.
Ehara H; Takafuji Y; Tatsumi K; Okada K; Mizukami Y; Kawao N; Matsuo O; Kaji H
Endocr J; 2021 Dec; 68(12):1421-1428. PubMed ID: 34248092
[TBL] [Abstract][Full Text] [Related]
14. Glycine Regulates Protein Turnover by Activating Protein Kinase B/Mammalian Target of Rapamycin and by Inhibiting MuRF1 and Atrogin-1 Gene Expression in C2C12 Myoblasts.
Sun K; Wu Z; Ji Y; Wu G
J Nutr; 2016 Dec; 146(12):2461-2467. PubMed ID: 27798331
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone regulates the actions of endogenous insulin-like growth factor-II during myogenic differentiation.
Yoshiko Y; Hirao K; Maeda N
Life Sci; 1998; 63(2):77-85. PubMed ID: 9674941
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells.
Kimura H; Li X; Torii K; Okada T; Kamiyama K; Mikami D; Kasuno K; Takahashi N; Yoshida H
Clin Exp Nephrol; 2011 Feb; 15(1):34-40. PubMed ID: 21042829
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
18. Effects of dimethyl sulphoxide and dexamethasone on mRNA expression of myogenesis- and muscle proteolytic system-related genes in mouse myoblastic C2C12 cells.
Nishimura M; Mikura M; Hirasaka K; Okumura Y; Nikawa T; Kawano Y; Nakayama M; Ikeda M
J Biochem; 2008 Dec; 144(6):717-24. PubMed ID: 18835828
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
[TBL] [Abstract][Full Text] [Related]
20. Dosing schedule-dependent attenuation of dexamethasone-induced muscle atrophy in mice.
Nakao R; Yamamoto S; Yasumoto Y; Oishi K
Chronobiol Int; 2014 May; 31(4):506-14. PubMed ID: 24397304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
